210 related articles for article (PubMed ID: 27713295)
21. Rebamipide as a Potential Alternative Gastroprotective Agent to Proton Pump Inhibitor in Elderly Chronic Nonsteroidal Anti-Inflammatory Drug Users without Risk Factors.
Lee MY; Lee S; Heo KN; Kim WY; Jung SH; Ah YM; Lee JY
Int J Gen Med; 2022; 15():2835-2845. PubMed ID: 35300126
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury.
Leonard CE; Freeman CP; Newcomb CW; Reese PP; Herlim M; Bilker WB; Hennessy S; Strom BL
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1155-72. PubMed ID: 22887960
[TBL] [Abstract][Full Text] [Related]
23. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
[TBL] [Abstract][Full Text] [Related]
24. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
25. Mucoprotective drugs can prevent and treat nonsteroidal anti-inflammatory drug-induced small bowel enteropathy: a systematic review and meta-analysis of randomized controlled trials.
Teutsch B; Boros E; Váncsa S; Váradi A; Frim L; Kiss S; Dembrovszky F; Helyes Z; Patrícia S; Péter H; Erőss B
Therap Adv Gastroenterol; 2021; 14():17562848211038772. PubMed ID: 34616487
[TBL] [Abstract][Full Text] [Related]
26. Risk factors of symptomatic NSAID-induced small intestinal injury and diaphragm disease.
Ishihara M; Ohmiya N; Nakamura M; Funasaka K; Miyahara R; Ohno E; Kawashima H; Itoh A; Hirooka Y; Watanabe O; Ando T; Goto H
Aliment Pharmacol Ther; 2014 Sep; 40(5):538-47. PubMed ID: 25041257
[TBL] [Abstract][Full Text] [Related]
27. Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy.
Montagnani S; Tuccori M; Testi A; Cristofano M; Corona T; Salvadori S; Scarpignato C; Blandizzi C
Int J Clin Pharm; 2016 Aug; 38(4):829-37. PubMed ID: 27003828
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
Wallace JL; Syer S; Denou E; de Palma G; Vong L; McKnight W; Jury J; Bolla M; Bercik P; Collins SM; Verdu E; Ongini E
Gastroenterology; 2011 Oct; 141(4):1314-22, 1322.e1-5. PubMed ID: 21745447
[TBL] [Abstract][Full Text] [Related]
29. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
Dajani EZ; Agrawal NM
Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges.
Lim YJ; Chun HJ
Gastroenterol Res Pract; 2013; 2013():761060. PubMed ID: 24159330
[TBL] [Abstract][Full Text] [Related]
31. Mucus reduction promotes acetyl salicylic acid-induced small intestinal mucosal injury in rats.
Suyama Y; Handa O; Naito Y; Takayama S; Mukai R; Ushiroda C; Majima A; Yasuda-Onozawa Y; Higashimura Y; Fukui A; Dohi O; Okayama T; Yoshida N; Katada K; Kamada K; Uchiyama K; Ishikawa T; Takagi T; Konishi H; Itoh Y
Biochem Biophys Res Commun; 2018 Mar; 498(1):228-233. PubMed ID: 29501492
[TBL] [Abstract][Full Text] [Related]
32. In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors.
Renga B; Mencarelli A; Cipriani S; D'Amore C; Francisci D; Santucci L; Baldelli F; Distrutti E; Fiorucci S
Eur J Pharmacol; 2014 Jan; 723():194-201. PubMed ID: 24315932
[TBL] [Abstract][Full Text] [Related]
33. [Prevention and treatment of NSAIDs-induced small intestinal lesions].
Yoda Y; Umegaki E; Higuchi K
Nihon Rinsho; 2011 Jun; 69(6):1093-7. PubMed ID: 21688634
[TBL] [Abstract][Full Text] [Related]
34. Protective Effect of Irsogladine against Aspirin-Induced Mucosal Injury in Human Induced Pluripotent Stem Cell-Derived Small Intestine.
Kanno T; Katano T; Ogawa I; Iwao T; Matsunaga T; Kataoka H
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676718
[No Abstract] [Full Text] [Related]
35. Nonsteroidal, antiinflammatory drug-induced gastrointestinal injuries and related adverse reactions: epidemiology, pathogenesis and management.
Al Mofleh IA; Al Rashed RS
Saudi J Gastroenterol; 2007; 13(3):107-13. PubMed ID: 19858625
[TBL] [Abstract][Full Text] [Related]
36. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
Lazzaroni M; Porro GB
Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
[TBL] [Abstract][Full Text] [Related]
37. Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole.
Higuchi K; Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Takeuchi K; Umegaki E
J Clin Biochem Nutr; 2009 Sep; 45(2):125-30. PubMed ID: 19794918
[TBL] [Abstract][Full Text] [Related]
38. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells.
Nagano Y; Matsui H; Shimokawa O; Hirayama A; Tamura M; Nakamura Y; Kaneko T; Rai K; Indo HP; Majima HJ; Hyodo I
J Physiol Pharmacol; 2012 Apr; 63(2):137-42. PubMed ID: 22653900
[TBL] [Abstract][Full Text] [Related]
39. [Pathogenic mechanism of NSAIDs-induced mucosal injury in lower gastrointestinal tract].
Beppu K; Osada T; Shibuya T; Watanabe S
Nihon Rinsho; 2011 Jun; 69(6):1083-7. PubMed ID: 21688632
[TBL] [Abstract][Full Text] [Related]
40. Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs.
Isomura Y; Yamaji Y; Yamada A; Watanabe Y; Suzuki H; Kobayashi Y; Yoshida S; Watabe H; Hirata Y; Yoshida H; Koike K
Gastrointest Endosc; 2014 Jul; 80(1):118-25. PubMed ID: 24518124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
